Search

The weeklong tariff threats and (this morning) levies have caused a consistent wave of selling this week, which, as we write, has brought most major indexes down to (or a bit below) their 50-day moving averages.

One of our stocks reported Q1 results this morning that came in better than expected. Even though the stock ran up 20% in the week leading up to the earnings report, shares blew through their prior all-time high following the report. Shares are trading between 10% and 15% higher at mid-day today, which pegs our current gain at 30% to 35%.

This week we are adding a covered call in yet another earnings season winner that has emerged amidst the rubble of the retail sector.

Today, I’m adding an American petroleum contract drilling company, Helmerich & Payne, Inc. (HP).

After pushing into correction territory towards the latter part of January, the broad market seems, if only temporarily, to have found a foundation, as it rose four of the five days last week. The Dow gained 1.0%, the S&P 500 bounced 1.5% and the tech-heavy Nasdaq pushed higher by 2.4%. Year-to-date the Dow, S&P 500 and Nasdaq are lower by 3.4%, 5.6% and 9.9%, respectively.
Today, I’m adding specialty metals company Allegheny Technologies (ATI).

The indexes plummeted on rising rate worries and disappointing Goldman Sachs (GS) earnings. The benchmark 10-year Treasury rate soared to 1.85 on Tuesday. That’s the highest level since the pandemic began and up from 1.34% as recently as last month.

I recently had the opportunity to talk to one of ours editors who you don’t hear from regularly in Cabot Wealth Advisory, Thomas Garrity, editor of Cabot Small-Cap Confidential. Today I’ve got a Q&A to share with you about why Tom prefers to invest in small-caps, what he thinks the best investment strategy is now and in the long-term. I hope you enjoy it! (Interesting side note: The Russell 2000 index of small-cap stocks pushed above the 50-day moving average on Wednesday--the first time since the market collapse began in September.)

Want to know how to find small-cap stocks? Here are my five rules for investing in these high-return, high-risk investments.

Apple will soon see its weighting on the Nasdaq 100 reduced, just like Microsoft did in 1998.

There’s an intriguing private medical device maker that may soon come public on the NYSE. Here’s how you can invest in this biotech stock before its IPO.

Cabot Stock of the Month Report is a great publication for people new to investing, or new to Cabot. It gives subscribers a taste of five of Cabot’s newsletters, allowing them to decide which investing system is right for them. By offering something from each of Cabot’s publications, it introduces you to several different investing systems, helping you decide which one is right for you. It also provides a diverse selection of stocks.

After all investors have bought, the sellers eventually take control. After you’re #1, there’s only one way to go. That’s one reason the dollar, which you might view as a proxy for the value of the U.S., is down. It was previously perceived to be the most powerful currency on earth; in recent years its reputation has been in decline. But I’m firmly convinced the long-term trend of the U.S. economy--and thus the U.S. stock market--is still up, and that the market will reflect that by climbing out to new highs eventually. And the time to invest is when public perception is lowest! It seems to me we’re pretty much there.

Today’s stock pick is a solar power company that changed its name from MEMC Electronic Materials.

I’m pleased to announce that earlier this week, Cabot launched its new, and improved, Web site. You may have noticed the changes, but if not, check them out now.

Welcome to the fourth installment about my recent 17-day, 4,218-mile road trip to and through the American Midwest and back—which I’m presenting not chronologically but thematically. Today’s theme is wine—American wine—with a focus on the grapes that originated in America.

The first news is the renaming of our advisory, from Cabot Marijuana Investor to Cabot Sector Xpress Cannabis Advisor, which is explained in today’s issue.

While the broad market was falling apart over the past week, several of our cannabis stocks held firm above their December lows, telling us that after an 11-month downtrend, the selling pressures are pretty much spent in that sector.



Today’s issue brings a few tweaks to our portfolio, but no big changes, as we are well positioned for the sector’s next uptrend.



Full details in the issue.